Irish Residential Properties (IRES)
Irish Exchange · Ireland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 1.268 |
|---|---|
| 52-week range | 0.894 – 1.318 |
| Return, 1 month / 3 months | +15.9% / +12.2% |
| Return, 1 year / 3 years | +35.0% / +38.4% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -11.4% |
| Average daily value traded | 2.63M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Irish Residential Properties is a real estate investment trust that owns and rents apartments in Ireland, with its portfolio concentrated in the Dublin area. The company provides residential accommodation to private tenants, letting flats in purpose-built developments and managing the buildings it owns. Its business is focused on the private rented residential market in Irish cities, and it operates as a landlord collecting rent from individual households rather than from commercial occupiers.
On this site Irish Residential Properties appears as a stock on the Irish Exchange (Ireland), code IRES, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Irish Residential Properties (IRES) trades on the Irish Exchange in Ireland. It last closed at EUR 1.268 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 5 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.0% and over the last three months it rose 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Irish Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.5% | ||
| From 52-week high | -2.5% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.2% | ||
| 6-month return | 21.7% | ||
| 12-month return, skipping the last month | 16.5% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.4% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.63M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +15.9% |
| 3 months | +12.2% |
| 6 months | +21.7% |
| 1 year | +35.0% |
| 3 years | +38.4% |
| 5 years | −14.2% |
Signals
| 50-day / 200-day average | 1.158 / 1.088 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.027 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2023 | EUR 0.0245 |
| 9 Mar 2023 | EUR 0.0281 |
| 18 Aug 2022 | EUR 0.0230 |
| 3 Mar 2022 | EUR 0.0308 |
| 19 Aug 2021 | EUR 0.0291 |
| 25 Mar 2021 | EUR 0.0322 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Irish Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.